Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis

Authors: James Brown, Kristina Clark, Colette Smith, Jennifer Hopwood, Oliver Lynard, Michael Toolan, Dean Creer, Jack Barker, Ronan Breen, Tim Brown, Ian Cropley, Marc Lipman

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

The C - reactive protein (CRP) response is often measured in patients with active tuberculosis (TB) yet little is known about its relationship to clinical features in TB, or whether responses differ between ethnic groups or with different Mycobacterium tuberculosis (M.tb) strain types. We report the relationship between baseline serum CRP prior to treatment and disease characteristics in a metropolitan population with TB resident in a low TB incidence region.

Methods

People treated for TB at four London, UK sites between 2003 and 2014 were assessed and data collected on the following characteristics: baseline CRP level; demographics (ethnicity, gender and age); HIV status; site of TB disease; sputum smear (in pulmonary cases) and culture results. The effect of TB strain-type was also assessed in culture-positive pulmonary cases using VNTR typing data.

Results

Three thousands two hundred twenty-two patients were included in the analysis of which 72 % had a baseline CRP at or within 4 weeks prior to starting TB treatment. CRP results were significantly higher in culture positive cases compared to culture negative cases: median 49 mg/L (16–103 mg/L) vs 19 mg/L (IQR 5–72 mg/L), p = <0.001. In those with pulmonary disease, smear positive cases had a higher CRP than smear negative cases: 67 mg/L (31–122 mg/L) vs 24 mg/L (7–72 mg/L), p < 0.001. HIV positive cases had higher baseline CRPs than HIV negative cases: 75 mg/L (26–136 mg/L) vs 37 mg/L (10–88 mg/L), p <0.001. Differing sites of disease were associated with differences in baseline CRP: locations that might be expected to have a high mycobacterial load (e.g. pulmonary disease and disseminated disease) had a significantly higher CRP than those such as skin, lymph node or CNS disease, where the mycobacterial load is typically low in HIV negative subjects. In a multivariable log-scale linear regression model adjusting for host characteristics and M.tb strain type, infection with the East African Indian strain was associated with significantly lower baseline-CRP (fold-change in CRP 0.51 (0.34–0.77), p < 0.01).

Conclusions

Host and mycobacterial factors are strongly associated with baseline CRP response in tuberculosis. This analysis suggests that there are important differences in innate immune response according to ethnicity, Mtb strain type and site of disease. This may reflect differing mycobacterial loads or host immune responses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Agassandian M, Shurin GV, Ma Y, Shurin MR. C-reactive protein and lung diseases. The International Journal of Biochemistry & Cell Biology. 2014;53:77–88.CrossRef Agassandian M, Shurin GV, Ma Y, Shurin MR. C-reactive protein and lung diseases. The International Journal of Biochemistry & Cell Biology. 2014;53:77–88.CrossRef
3.
go back to reference Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean J Intern Med. 2009;24(4):337–42.CrossRefPubMedPubMedCentral Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean J Intern Med. 2009;24(4):337–42.CrossRefPubMedPubMedCentral
4.
go back to reference Drain PK, Mayeza L, Bartman P, Hurtado R, Moodley P, Varghese S, Maartens G, Alvarez GG, Wilson D. Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa. Int J Tuberc Lung Dis. 2014;18(1):20–6.CrossRefPubMedPubMedCentral Drain PK, Mayeza L, Bartman P, Hurtado R, Moodley P, Varghese S, Maartens G, Alvarez GG, Wilson D. Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa. Int J Tuberc Lung Dis. 2014;18(1):20–6.CrossRefPubMedPubMedCentral
5.
go back to reference Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Int J Tuberc Lung Dis. 2013;17(5):636–43.CrossRefPubMed Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Int J Tuberc Lung Dis. 2013;17(5):636–43.CrossRefPubMed
6.
go back to reference Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, et al. Concurrent anemia and elevated C-reactive protein predicts HIV clinical treatment failure, including tuberculosis, after antiretroviral therapy initiation. Clin Infect Dis. 2015;61(1):102–10.CrossRefPubMedPubMedCentral Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, et al. Concurrent anemia and elevated C-reactive protein predicts HIV clinical treatment failure, including tuberculosis, after antiretroviral therapy initiation. Clin Infect Dis. 2015;61(1):102–10.CrossRefPubMedPubMedCentral
7.
go back to reference Djoba Siawaya JF, Chegou NN, van den Heuvel MM, Diacon AH, Beyers N, van Helden P, Walzl G. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine. 2009;47(2):132–6.CrossRefPubMed Djoba Siawaya JF, Chegou NN, van den Heuvel MM, Diacon AH, Beyers N, van Helden P, Walzl G. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine. 2009;47(2):132–6.CrossRefPubMed
8.
go back to reference Huang CT, Lee LN, Ho CC, Shu CC, Ruan SY, Tsai YJ, Wang JY, Yu CJ. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis. J Infect. 2014;68(5):440–7.CrossRefPubMed Huang CT, Lee LN, Ho CC, Shu CC, Ruan SY, Tsai YJ, Wang JY, Yu CJ. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis. J Infect. 2014;68(5):440–7.CrossRefPubMed
9.
go back to reference Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, et al. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. Tuberculosis (Edinburgh, Scotland). 2015;95(4):415–20.CrossRef Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, et al. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. Tuberculosis (Edinburgh, Scotland). 2015;95(4):415–20.CrossRef
10.
go back to reference Fenner L, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, lbling P, Fehr J, Gsponer T, Rieder HL, et al. HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genetics. 2013;9(3):e1003318. Fenner L, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, lbling P, Fehr J, Gsponer T, Rieder HL, et al. HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genetics. 2013;9(3):e1003318.
11.
go back to reference Portevin D, Gagneux S, Comas I, Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011;7(3):e1001307.CrossRefPubMedPubMedCentral Portevin D, Gagneux S, Comas I, Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011;7(3):e1001307.CrossRefPubMedPubMedCentral
12.
go back to reference Coussens AK, Wilkinson RJ, Nikolayevskyy V, Elkington PT, Hanifa Y, Islam K, Timms PM, Bothamley GH, Claxton AP, Packe GE, et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog. 2013;9(7):e1003468.CrossRefPubMedPubMedCentral Coussens AK, Wilkinson RJ, Nikolayevskyy V, Elkington PT, Hanifa Y, Islam K, Timms PM, Bothamley GH, Claxton AP, Packe GE, et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog. 2013;9(7):e1003468.CrossRefPubMedPubMedCentral
13.
go back to reference England PH. Tuberculosis in London: Annual review (2013 data). London: Public Health England; 2014. England PH. Tuberculosis in London: Annual review (2013 data). London: Public Health England; 2014.
14.
go back to reference Aguilar D, Hanekom M, Mata D, van Pittius NC G, van Helden PD, Warren RM, Hernandez-Pando R. Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis (Edinburgh, Scotland). 2010;90(5):319–25.CrossRef Aguilar D, Hanekom M, Mata D, van Pittius NC G, van Helden PD, Warren RM, Hernandez-Pando R. Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis (Edinburgh, Scotland). 2010;90(5):319–25.CrossRef
15.
go back to reference Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002;10(1):45–52.CrossRefPubMed Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002;10(1):45–52.CrossRefPubMed
16.
go back to reference Jayalakshmi P, Malik AK, Soo-Hoo HS. Histopathology of lymph nodal tuberculosis--university hospital experience. The Malaysian Journal of Pathology. 1994;16(1):43–7.PubMed Jayalakshmi P, Malik AK, Soo-Hoo HS. Histopathology of lymph nodal tuberculosis--university hospital experience. The Malaysian Journal of Pathology. 1994;16(1):43–7.PubMed
17.
go back to reference Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21(2):243–61. Table of contents.CrossRefPubMedPubMedCentral Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21(2):243–61. Table of contents.CrossRefPubMedPubMedCentral
18.
go back to reference Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C, et al. The mortality and pathology of HIV infection in a west African city. Aids. 1993;7(12):1569–79.CrossRefPubMed Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C, et al. The mortality and pathology of HIV infection in a west African city. Aids. 1993;7(12):1569–79.CrossRefPubMed
19.
go back to reference Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Revista portuguesa de pneumologia. 2009;15(1):129–32.CrossRefPubMed Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Revista portuguesa de pneumologia. 2009;15(1):129–32.CrossRefPubMed
20.
go back to reference Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008;121(3):219–25.CrossRefPubMed Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008;121(3):219–25.CrossRefPubMed
21.
go back to reference Jacobs R, Tshehla E, Malherbe S, Kriel M, Loxton AG, Stanley K, van der Spuy G, Walzl G, Chegou NN. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment. Cytokine. 2016;81:50–6.CrossRefPubMed Jacobs R, Tshehla E, Malherbe S, Kriel M, Loxton AG, Stanley K, van der Spuy G, Walzl G, Chegou NN. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment. Cytokine. 2016;81:50–6.CrossRefPubMed
22.
go back to reference Petrone L, Cannas A, Aloi F, Nsubuga M, Sserumkuma J, Nazziwa RA, Jugheli L, Lukindo T, Girardi E, Reither K, et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. BioMed Research International. 2015;2015:589471.CrossRefPubMedPubMedCentral Petrone L, Cannas A, Aloi F, Nsubuga M, Sserumkuma J, Nazziwa RA, Jugheli L, Lukindo T, Girardi E, Reither K, et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. BioMed Research International. 2015;2015:589471.CrossRefPubMedPubMedCentral
23.
go back to reference Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21.CrossRefPubMedPubMedCentral Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21.CrossRefPubMedPubMedCentral
24.
go back to reference Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rusch-Gerdes S, Mokrousov I, Aleksic E, et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nature Genetics. 2015;47(3):242–9.CrossRefPubMed Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rusch-Gerdes S, Mokrousov I, Aleksic E, et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nature Genetics. 2015;47(3):242–9.CrossRefPubMed
Metadata
Title
Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis
Authors
James Brown
Kristina Clark
Colette Smith
Jennifer Hopwood
Oliver Lynard
Michael Toolan
Dean Creer
Jack Barker
Ronan Breen
Tim Brown
Ian Cropley
Marc Lipman
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1612-1

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue